Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary

Neelima Denduluri; Mark R. Somerfield; Antonio C Wolff

doi:10.1200/JOP.2016.012344

Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary

Neelima Denduluri, Mark R. Somerfield, Antonio C Wolff

School of Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	485-488
Number of pages	4
Journal	Journal of Oncology Practice
Volume	12
Issue number	5
DOIs	https://doi.org/10.1200/JOP.2016.012344
State	Published - May 1 2016

ASJC Scopus subject areas

Oncology
Oncology(nursing)
Health Policy

Access to Document

10.1200/JOP.2016.012344

Cite this

Denduluri, N., Somerfield, M. R., & Wolff, A. C. (2016). Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary. Journal of Oncology Practice, 12(5), 485-488. https://doi.org/10.1200/JOP.2016.012344

Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary. / Denduluri, Neelima; Somerfield, Mark R.; Wolff, Antonio C.
In: Journal of Oncology Practice, Vol. 12, No. 5, 01.05.2016, p. 485-488.

Research output: Contribution to journal › Article › peer-review

Denduluri, N, Somerfield, MR & Wolff, AC 2016, 'Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary', Journal of Oncology Practice, vol. 12, no. 5, pp. 485-488. https://doi.org/10.1200/JOP.2016.012344

Denduluri N, Somerfield MR, Wolff AC. Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary. Journal of Oncology Practice. 2016 May 1;12(5):485-488. doi: 10.1200/JOP.2016.012344

Denduluri, Neelima ; Somerfield, Mark R. ; Wolff, Antonio C. / Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers : An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary. In: Journal of Oncology Practice. 2016 ; Vol. 12, No. 5. pp. 485-488.

@article{a7d9bd249f794645b7da792540d00325,

title = "Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary",

author = "Neelima Denduluri and Somerfield, {Mark R.} and Wolff, {Antonio C}",

year = "2016",

month = may,

day = "1",

doi = "10.1200/JOP.2016.012344",

language = "English (US)",

volume = "12",

pages = "485--488",

journal = "Journal of Oncology Practice",

issn = "1554-7477",

publisher = "American Society of Clinical Oncology",

number = "5",

}

TY - JOUR

T1 - Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers

T2 - An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary

AU - Denduluri, Neelima

AU - Somerfield, Mark R.

AU - Wolff, Antonio C

PY - 2016/5/1

Y1 - 2016/5/1

UR - http://www.scopus.com/inward/record.url?scp=84969150982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969150982&partnerID=8YFLogxK

U2 - 10.1200/JOP.2016.012344

DO - 10.1200/JOP.2016.012344

M3 - Article

C2 - 27118160

AN - SCOPUS:84969150982

SN - 1554-7477

VL - 12

SP - 485

EP - 488

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

IS - 5

ER -

Selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for HER2-positive breast cancers: An American society of clinical oncology guideline adaptation of the cancer care Ontario clinical practice guideline summary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this